Replies to post #7653 on The Nooner

[PoemStone]

from [handle1] FROI. FROI should be reporting middle of May.



I wonder what are the Sucanon® Sales in Mexico?

*FROI expected both revenues and margins to grow dramatically as new patients adopt Sucanon® into their daily type-2 diabetes management routine, and Sucanon distribution expands beyond Mexico to include countries in South America, Asia, and the Middle East."



About Sucanon

Sucanon® is one of only three approved drugs in the multi-billion dollar market for a class of diabetic medications called "insulin sensitizers." Pre-clinical and clinical studies show that Sucanon® and other insulin sensitizers lower a patient's blood sugar by increasing the muscle, fat and liver's sensitivity to the body's own naturally produced insulin. Sucanon® has been approved for prescription sale in China and Peru. Sucanon® is also approved as an OTC treatment for type-2 diabetes by regulatory authorities in Mexico, and is distributed there under an exclusive agreement with Merck S.A. de C.V.

HOW??
* FROI expanded Sucanon® retail distribution throughout Mexico from 900 points-of-sale to over 2,500 outlets and pharmacy chains. Sucanon® is available over-the-counter in Mexico from many well-known retailers including WalMart Supercenters, Superama, Farmacias del Ahorro, Comercial Mexicana, Farmacias Guadalajara, Soriana, Farmacias San Pablo, and Gusher Farmacias.

"Due to the excellent performance of Merck S.A. de C.V. as our business partners, Sucanon® is well positioned on the most important retail shelves throughout Mexico," said Mr. Luis M. Lopez, Chief Operating Officer of Fero Industries Inc. and President of Pharmaroth S.A., the Company's Mexican subsidiary. "This rapid expansion of distribution has placed Sucanon® and Sucanon® related marketing material in almost three times as many retail stores and should continue to boost market awareness and acceptance of Sucanon® as an over-the-counter treatment for type-2 diabetes across Mexico."

For further information regarding Sucanon®, please visit the Fero Industries Inc. website at www.feroindustries.com, email us at [e-mail], or call toll-free [phone].


*Shareholders and other interested parties can review the financial statements from the Securities and Exchange Commission website at www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001409475. Further information is also available exclusively at the Fero Industries Investor Community online at www.livecallir.com.